All Releases
 |
Athersys to Host Fourth Quarter Financial Results Call
Feb 25, 2010
|
9.8 KB |
|
| |
CLEVELAND, Feb 25, 2010 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its fourth quarter 2009 financial results at approximately 4:00 PM (Eastern Time) on Thursday, March 11, 2010, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen...
|
|
Athersys Announces Completion of Patient Enrollment in Phase I Study of Multistem(R) in Acute Myocardial Infarction
Feb 16, 2010
|
13.7 KB |
|
| |
CLEVELAND, Feb 16, 2010 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced that it has completed patient enrollment for its phase I clinical trial of MultiStem(R), its allogeneic stem cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a hea...
|
|
Athersys Receives U.S. Patent Covering Adult Stem Cell Composition & Production
Feb 10, 2010
|
13.0 KB |
|
| |
CLEVELAND, Feb 10, 2010 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has been granted U.S. patent 7,659,118 that covers non-embryonic multipotent stem cells, their isolation and expansion, and related pharmaceutical compositions. Athersys also announced that it has been granted -- and the oppositio...
|
|
Athersys to Present at 12th Annual BIO CEO & Investor Conference
Feb 2, 2010
|
11.1 KB |
|
| |
CLEVELAND, Feb 2, 2010 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it will present at the 12th Annual BIO CEO & Investor Conference to be held at the Waldorf-Astoria Hotel, February 8-9, 2010, in New York City. The conference will provide a forum to discuss breakthrough therapeutic developments and i...
|
|
Athersys Files Shelf Registration Statement
Jan 14, 2010
|
11.2 KB |
|
| |
CLEVELAND, Jan 14, 2010 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has filed a shelf registration statement with the Securities and Exchange Commission ("SEC"). Athersys currently does not have any immediate plans to offer or sell the securities under this registration statement. The registration...
|
|
Athersys Enters Into Global Agreement With Pfizer to Develop and Market MultiStem(R) for the Treatment of Inflammatory Bowel Disease
Dec 21, 2009
|
13.6 KB |
|
| |
CLEVELAND, Dec 21, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has entered into an agreement with Pfizer Inc. (PFE) to develop and commercialize MultiStem(R) for the treatment of Inflammatory Bowel Disease ("IBD"). MultiStem is an investigational stem cell therapy currently in development by ...
|
|
Athersys Reports 2009 Third Quarter Results
Nov 5, 2009
|
16.7 KB |
|
| |
CLEVELAND, Nov 5, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the quarter ended September 30, 2009. Third Quarter Highlights Include:
* Continued enrollment in two MultiStem(R) phase I clinical trials
for patients who suffer an acute myocardial infarction (AMI...
|
|
Athersys to Host Third Quarter 2009 Financial Results Call
Oct 20, 2009
|
10.0 KB |
|
| |
CLEVELAND, Oct 20, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its third quarter 2009 financial results at approximately 4:00 PM (Eastern Time) on Thursday, November 5, 2009, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkele...
|
|
Athersys Reports 2009 Second Quarter Results
Aug 6, 2009
|
17.3 KB |
|
| |
CLEVELAND, Aug 6, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the quarter ended June 30, 2009.
Second Quarter Highlights Include:
-- Continued enrollment in two MultiStem(r) phase I clinical trials,
for patients who suffer an acute myocardial infarction...
|
|
Athersys to Host Second Quarter 2009 Financial Results Call
Jul 20, 2009
|
10.0 KB |
|
| |
CLEVELAND, Jul 20, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its second quarter 2009 financial results at approximately 4:00 PM (Eastern Time) on Thursday, August 6, 2009, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen...
|
|
Athersys Reports 2009 First Quarter Results
May 7, 2009
|
20.4 KB |
|
| |
CLEVELAND, May 7, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the quarter ended March 31, 2009.
First Quarter and Recent Highlights Include:
* Ongoing enrollment in two MultiStem(r) phase I clinical trials, for
the treatment of acute myocardial infarction ...
|
|
Athersys to Host First Quarter 2009 Financial Results Call
Apr 14, 2009
|
10.0 KB |
|
| |
CLEVELAND, Apr 14, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its first quarter 2009 financial results at approximately 4:00 PM (Eastern Time) on Thursday, May 7, 2009, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen, Ch...
|
|
Athersys, Inc. (ATHX) Chairman and Chief Executive Officer to Ring The NASDAQ Stock Market Closing Bell
Apr 7, 2009
|
11.2 KB |
|
| |
ADVISORY, Apr 7, 2009 (GlobeNewswire via COMTEX News Network) --
What:
Gil Van Bokkelen, Chairman and Chief Executive Officer of Athersys,
Inc. (ATHX), will preside over the Closing Bell.
Where:
NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio
When:
Wednesday, April 8, 2009 at 3:45 p.m. to 4:00 p.m. ET
...
|
|
Reminder: Athersys' First Annual Investor Day On April 8, 2009 in New York City
Apr 7, 2009
|
16.1 KB |
|
| |
CLEVELAND, Apr 7, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced highlights for its first annual Investor Day being held at the Intercontinental Hotel on Wednesday, April 8th, 2009 in New York City. As a reminder, the meeting will begin promptly at 8:30 a.m. Eastern Time and end at approximately 11:30 a...
|
|
Athersys to Present At Cowen and Company 29th Annual Health Care Conference
Mar 13, 2009
|
10.0 KB |
|
| |
CLEVELAND, Mar 13, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will present at the Cowen and Company 29th Annual Health Care Conference, to be held March 16-19, 2009, at The Boston Marriott Copley Place.
William (B.J.) Lehmann, President and Chief Operating Officer, will present on Tuesday, Ma...
|
|
Athersys Reports Fourth Quarter and 2008 Annual Results
Mar 12, 2009
|
21.7 KB |
|
| |
CLEVELAND, Mar 12, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the fourth quarter of 2008 and for the year ended December 31, 2008.
Fourth Quarter and Recent Highlights Include:
* Continued enrollment in two MultiStem(r) phase I clinical trials,
for acute ...
|
|
Athersys to Host First Annual Investor Day to Highlight Progress in Stem Cell and Drug Development Programs
Mar 4, 2009
|
16.5 KB |
|
| |
CLEVELAND, Mar 4, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will host its first annual Investor Day being held at the Intercontinental Hotel on Wednesday, April 8th, 2009 in New York City. The meeting will begin promptly at 8:30 a.m. Eastern Time and end at approximately 11:30 a.m. Eastern Time....
|
|
Athersys to Host Fourth Quarter 2008 Financial Results Call
Feb 11, 2009
|
10.0 KB |
|
| |
CLEVELAND, Feb 11, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its fourth quarter 2008 financial results at approximately 4:00 PM (Eastern Time) on Thursday, March 12, 2009, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen...
|
|
Athersys to Present At 4th Annual Stem Cell Summit
Jan 27, 2009
|
10.8 KB |
|
| |
CLEVELAND, Jan 27, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced that William (B.J.) Lehmann, President and Chief Operating Officer, will present at the 4th Annual Stem Cell Summit on Tuesday, February 17, 2009, at Bridgewaters, in New York City. The annual Stem Cell Summit is the premier gathering of ...
|
|
Athersys to Present At 5th Annual Cell and Gene Therapy Forum
Jan 9, 2009
|
9.9 KB |
|
| |
CLEVELAND, Jan 9, 2009 (GlobeNewswire via COMTEX News Network) -- Athersys, Inc. (Nasdaq:ATHX) today announced that Dr. Gil Van Bokkelen, Chairman & Chief Executive Officer, will present at the 5th annual Phacilitate Cell and Gene Therapy Forum in Washington D.C. on Monday, January 26th, 2009. Dr. Van Bokkelen will present on recent progress in the...
|
|
|
= add release to Briefcase |
|
 |
|
Mar 10, 2010
4:00 PM ET
$3.10  0.01
Quotes delayed at least 20 minutes.
Information provided by eSignal.
|
|
 |
|
